Trump’s ‘Buy American’ order on essential drugs looks ‘toothless,’ analysts say

Analysts are predicting there won’t be a big impact on the pharmaceutical industry from President Donald Trump’s latest executive order, which requires the U.S. government buy “essential” drugs from American companies.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.